VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Vor Biopharma Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$18.04+0.01 (+0.06%)
Close on Oct 19, 2026
- Market cap
- $979.65M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Vor Biopharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 6, 2026 | Jul 7, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 8, 2026 | Jun 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 23, 2026 | Apr 27, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 31, 2025 | Jan 2, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 15, 2025 | Dec 18, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 5, 2025 | Dec 9, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 2, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 28, 2025 | Oct 28, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2025 | Sep 17, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2025 | Sep 2, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 25, 2025 | Aug 27, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 25, 2025 | Aug 27, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 25, 2025 | Aug 8, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 16, 2025 | Jul 22, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2025 | Jul 10, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2025 | Jun 26, 2025 | SEC EDGAR |
| Current report | 8-K | May 22, 2025 | May 23, 2025 | SEC EDGAR |
| Current report | 8-K | May 19, 2025 | May 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 5, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2025 | Apr 25, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 22, 2025 | Apr 8, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Apr 3, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2025 | Feb 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2025 | Jan 8, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 26, 2024 | Dec 27, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2024 | Dec 9, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2024 | Sep 30, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 5, 2024 | Sep 5, 2024 | SEC EDGAR |